116 related articles for article (PubMed ID: 7914128)
1. MDR1 gene expression in chronic lymphocytic leukemia.
Wallner J; Gisslinger H; Gisslinger B; Gsur A; Götzl M; Zöchbauer S; Pirker R
Leuk Lymphoma; 1994 Apr; 13(3-4):333-8. PubMed ID: 7914128
[TBL] [Abstract][Full Text] [Related]
2. Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay.
Ludescher C; Hilbe W; Eisterer W; Preuss E; Huber C; Gotwald M; Hofmann J; Thaler J
J Natl Cancer Inst; 1993 Nov; 85(21):1751-8. PubMed ID: 8105101
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistance phenotype in patients with chronic lymphocytic leukemia as detected by immunofluorescence (FACS) and northern blot analysis.
Wulf G; Kluding H; Ho AD; Doerner M; Doehner H; Manegold C; Hunstein W
Leuk Res; 1994 Jul; 18(7):475-84. PubMed ID: 7912754
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance (Mdr1) gene expression in peripheral blasts from patients with acute leukemia only rarely increases during disease progression after combination chemotherapy.
Gruber A; Areström I; Albertioni F; Björkholm M; Peterson C; Vitols S
Leuk Lymphoma; 1995 Aug; 18(5-6):435-42. PubMed ID: 8528050
[TBL] [Abstract][Full Text] [Related]
5. In vitro chemosensitivity of chronic lymphocytic leukemia B-cells to multidrug regimen (CEOP) compounds using the MTT colorimetric assay.
Morabito F; Messina G; Oliva B; Ramirez F; Callea V; Brugiatelli M; Nobile F
Haematologica; 1993; 78(4):213-8. PubMed ID: 8294052
[TBL] [Abstract][Full Text] [Related]
6. Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias.
Gekeler V; Frese G; Noller A; Handgretinger R; Wilisch A; Schmidt H; Muller CP; Dopfer R; Klingebiel T; Diddens H
Br J Cancer; 1992 Sep; 66(3):507-17. PubMed ID: 1355660
[TBL] [Abstract][Full Text] [Related]
7. High expression of the mdr3 multidrug-resistance gene in advanced-stage chronic lymphocytic leukemia.
Sonneveld P; Nooter K; Burghouts JT; Herweijer H; Adriaansen HJ; van Dongen JJ
Blood; 1992 Mar; 79(6):1496-500. PubMed ID: 1347708
[TBL] [Abstract][Full Text] [Related]
8. MDR1 RNA expression as a prognostic factor in acute myeloid leukemia: an update.
Gsur A; Zöchbauer S; Götzl M; Kyrle PA; Lechner K; Pirker R
Leuk Lymphoma; 1993 Dec; 12(1-2):91-4. PubMed ID: 7909245
[TBL] [Abstract][Full Text] [Related]
9. High mdr1- and mrp-, but low topoisomerase II alpha-gene expression in B-cell chronic lymphocytic leukaemias.
Beck J; Niethammer D; Gekeler V
Cancer Lett; 1994 Oct; 86(1):135-42. PubMed ID: 7954350
[TBL] [Abstract][Full Text] [Related]
10. PCR-determined expression of the MDR1 gene in chronic lymphocytic leukemia.
Rochlitz CF; de Kant E; Neubauer A; Heide I; Böhmer R; Oertel J; Huhn D; Herrmann R
Ann Hematol; 1992 Dec; 65(6):241-6. PubMed ID: 1360821
[TBL] [Abstract][Full Text] [Related]
11. Multidrug resistance gene (mdr1) RNA levels in relation to P-glycoprotein content of leukemic cells from patients with acute leukemia.
Albertioni F; Gruber A; Areström I; Vitols S
Med Oncol; 1995 Jun; 12(2):79-86. PubMed ID: 8535665
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous detection of MDR1 and WT1 gene expression to predict the prognosis of adult acute lymphoblastic leukemia.
Xu B; Song X; Yip NC; Xiao P; Zhang Y; Wang W; Zhou S
Hematology; 2010 Apr; 15(2):74-80. PubMed ID: 20423567
[TBL] [Abstract][Full Text] [Related]
13. Multi-drug resistance mediated by P-glycoprotein overexpression is not correlated with ZAP-70/CD38 expression in B-cell chronic lymphocytic leukemia.
Guillaume N; Gouilleux-Gruart V; Claisse JF; Troussard X; Lepelley P; Damaj G; Royer B; Garidi R; Lefrere JJ
Leuk Lymphoma; 2007 Aug; 48(8):1556-60. PubMed ID: 17701587
[TBL] [Abstract][Full Text] [Related]
14. Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia.
Klintman J; Appleby N; Stamatopoulos B; Ridout K; Eyre TA; Robbe P; Pascua LL; Knight SJL; Dreau H; Cabes M; Popitsch N; Ehinger M; Martín-Subero JI; Campo E; Månsson R; Rossi D; Taylor JC; Vavoulis DV; Schuh A
Blood; 2021 May; 137(20):2800-2816. PubMed ID: 33206936
[TBL] [Abstract][Full Text] [Related]
15. Expression of the MDR1 gene in human cancers.
Goldstein LJ; Gottesman MM; Pastan I
Cancer Treat Res; 1991; 57():101-19. PubMed ID: 1686712
[No Abstract] [Full Text] [Related]
16. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.
Jaksic B; Brugiatelli M; Krc I; Losonczi H; Holowiecki J; Planinc-Peraica A; Kusec R; Morabito F; Iacopino P; Lutz D
Cancer; 1997 Jun; 79(11):2107-14. PubMed ID: 9179056
[TBL] [Abstract][Full Text] [Related]
17. Drug resistance mechanisms in chronic lymphocytic leukemia.
Ribrag V; Massade L; Faussat AM; Dreyfus F; Bayle C; Gouyette A; Marie JP
Leukemia; 1996 Dec; 10(12):1944-9. PubMed ID: 8946935
[TBL] [Abstract][Full Text] [Related]
18. Thioredoxin-interacting protein and chronic lymphocytic leukemia.
Friday E; Koshy N; Bhanderi V; Turturro F
Leuk Lymphoma; 2012 Mar; 53(3):492-4. PubMed ID: 21916829
[No Abstract] [Full Text] [Related]
19. Comparison of fludarabine, cyclophosphamide/doxorubicin/prednisone, and cyclophosphamide/doxorubicin/vincristine/prednisone in advanced forms of chronic lymphocytic leukemia: preliminary results of a controlled clinical trial. The French Cooperative Group on Chronic Lymphocytic Leukemia.
Semin Oncol; 1993 Oct; 20(5 Suppl 7):21-3. PubMed ID: 8235691
[TBL] [Abstract][Full Text] [Related]
20. CHOP regimen versus intermittent chlorambucil-prednisone in stage B chronic lymphocytic leukemia. Short term results from a randomized clinical trial. French Cooperative Group on Chronic Lymphocytic Leukemia.
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):449-52. PubMed ID: 2906118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
